èšåºæ®µéã®è£œè¬äŒç€Ÿã§ãã Corbus Pharmaceuticals Holdings, Inc. ã¯ãèªå·±å
ç«ãç·ç¶çãããã³ããã®åéã§ãšã³ãã«ã³ãããã€ã ã·ã¹ãã ãã¿ãŒã²ãããšããæ°ããæ²»çè¬ã®éçºãšåååã«éç¹ã眮ããŠããŸãããã®äž»å補ååè£ã¯ãç®èççã®æ²»çã®ç¬¬ III çžèšåºè©Šéšãšå
šèº«æ§ãšãªããããŒãã¹ã®æ²»çã®ç¬¬ II çžèšåºè©Šéšãè¡ãããŠããã«ã³ãããã€ãå容äœã¿ã€ã 2 (CB2) ã§ããã¬ãããµã ã§ããå瀟ã¯ãŸããè¥æºãç³å°¿ç
æ§è
çãç³å°¿ç
æ§ç¶²èçãããã³éã¢ã«ã³ãŒã«æ§èèªèçãªã©ã®ä»£è¬éå®³ã®æ²»çã®ããã®ã«ã³ãããã€ãå容äœã¿ã€ã 1 éäœåè¬ããã°ã©ã ãããã³ããã®æ²»çã®ããã® CB2 äœåè¬ããã°ã©ã ãéçºäžã§ããå瀟㯠Jenrin Discovery, LLC ãšã©ã€ã»ã³ã¹å¥çŽãçµãã§ãããã©ã€ã»ã³ã¹è£œåã®éçºãšåååãè¡ã£ãŠããŸããããã«ã¯çŽ 600 ã®ååç©ãšè€æ°ã®çºè¡æžã¿ããã³ç³è«äžã®ç¹èš±ã® Jenrin ã©ã€ãã©ãªãå«ãŸããŸãããŸããç§ç è£œè¬æ ªåŒäŒç€ŸãšæŠç¥çææºãçµã³ãæ¥æ¬ã§ã®ã¬ãããµã ã®éçºãšåååã«åãçµãã§ããŸããå瀟㯠2009 幎ã«èšç«ãããããµãã¥ãŒã»ããå·ããŒãŠããã«æ ç¹ã眮ããŠããŸãã